FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175278429> ?p ?o ?g. }

• W3175278429 abstract "Variations in tumor biology from patient to patient combined with the low overall survival rate of hepatocellular carcinoma (HCC) present significant clinical challenges. During the progression of chronic liver diseases from inflammation to the development of HCC, microenvironmental properties, including tissue stiffness and oxygen concentration, change over time. This can potentially impact drug metabolism and subsequent therapy response to commonly utilized therapeutics, such as doxorubicin, multi-kinase inhibitors (e.g., sorafenib), and other drugs, including immunotherapies. In this study, we utilized four common HCC cell lines embedded in 3D collagen type-I gels of varying stiffnesses to mimic normal and cirrhotic livers with environmental oxygen regulation to quantify the impact of these microenvironmental factors on HCC chemoresistance. In general, we found that HCC cells with higher baseline levels of cytochrome p450-3A4 (CYP3A4) enzyme expression, HepG2 and C3Asub28, exhibited a cirrhosis-dependent increase in doxorubicin chemoresistance. Under the same conditions, HCC cell lines with lower CYP3A4 expression, HuH-7 and Hep3B2, showed a decrease in doxorubicin chemoresistance in response to an increase in microenvironmental stiffness. This differential therapeutic response was correlated with the regulation of CYP3A4 expression levels under the influence of stiffness and oxygen variation. In all tested HCC cell lines, the addition of sorafenib lowered the required doxorubicin dose to induce significant levels of cell death, demonstrating its potential to help reduce systemic doxorubicin toxicity when used in combination. These results suggest that patient-specific tumor microenvironmental factors, including tissue stiffness, hypoxia, and CYP3A4 activity levels, may need to be considered for more effective use of chemotherapeutics in HCC patients." @default.
• W3175278429 created "2021-07-05" @default.
• W3175278429 creator A5002263778 @default.
• W3175278429 creator A5027619317 @default.
• W3175278429 creator A5047166582 @default.
• W3175278429 creator A5056263186 @default.
• W3175278429 creator A5066645015 @default.
• W3175278429 creator A5066736885 @default.
• W3175278429 creator A5082444529 @default.
• W3175278429 date "2021-06-28" @default.
• W3175278429 modified "2023-10-18" @default.
• W3175278429 title "Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity" @default.
• W3175278429 cites W1517771226 @default.
• W3175278429 cites W1702807959 @default.
• W3175278429 cites W1968730264 @default.
• W3175278429 cites W1971837077 @default.
• W3175278429 cites W1981059065 @default.
• W3175278429 cites W1985656429 @default.
• W3175278429 cites W1987120610 @default.
• W3175278429 cites W2001306254 @default.
• W3175278429 cites W2009930854 @default.
• W3175278429 cites W2040633239 @default.
• W3175278429 cites W2050309886 @default.
• W3175278429 cites W2055275875 @default.
• W3175278429 cites W2057723124 @default.
• W3175278429 cites W2061368752 @default.
• W3175278429 cites W2064252921 @default.
• W3175278429 cites W2065296596 @default.
• W3175278429 cites W2073001877 @default.
• W3175278429 cites W2073066827 @default.
• W3175278429 cites W2077522929 @default.
• W3175278429 cites W2077967017 @default.
• W3175278429 cites W2100534366 @default.
• W3175278429 cites W2107297677 @default.
• W3175278429 cites W2130557824 @default.
• W3175278429 cites W2142376400 @default.
• W3175278429 cites W2149874329 @default.
• W3175278429 cites W2156656651 @default.
• W3175278429 cites W2157945371 @default.
• W3175278429 cites W2175593203 @default.
• W3175278429 cites W2217342753 @default.
• W3175278429 cites W2294798900 @default.
• W3175278429 cites W2341369626 @default.
• W3175278429 cites W2343413503 @default.
• W3175278429 cites W2411225414 @default.
• W3175278429 cites W2412179163 @default.
• W3175278429 cites W2416425138 @default.
• W3175278429 cites W2495512985 @default.
• W3175278429 cites W2530700316 @default.
• W3175278429 cites W2552699553 @default.
• W3175278429 cites W2562949639 @default.
• W3175278429 cites W2570618306 @default.
• W3175278429 cites W2571979441 @default.
• W3175278429 cites W2612918033 @default.
• W3175278429 cites W2624837600 @default.
• W3175278429 cites W2730718150 @default.
• W3175278429 cites W2740869100 @default.
• W3175278429 cites W2754940015 @default.
• W3175278429 cites W2767749330 @default.
• W3175278429 cites W2776354711 @default.
• W3175278429 cites W2781525129 @default.
• W3175278429 cites W2796067155 @default.
• W3175278429 cites W2804463612 @default.
• W3175278429 cites W2809687260 @default.
• W3175278429 cites W2883572895 @default.
• W3175278429 cites W2889481010 @default.
• W3175278429 cites W2890625366 @default.
• W3175278429 cites W2892987557 @default.
• W3175278429 cites W2896514396 @default.
• W3175278429 cites W290932385 @default.
• W3175278429 cites W2910534780 @default.
• W3175278429 cites W2911364339 @default.
• W3175278429 cites W2915893237 @default.
• W3175278429 cites W2925321055 @default.
• W3175278429 cites W2925867428 @default.
• W3175278429 cites W2972003656 @default.
• W3175278429 cites W2987490531 @default.
• W3175278429 cites W3016183802 @default.
• W3175278429 cites W3023135924 @default.
• W3175278429 cites W3115521799 @default.
• W3175278429 doi "https://doi.org/10.3389/fonc.2021.662135" @default.
• W3175278429 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8273608" @default.
• W3175278429 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34262860" @default.
• W3175278429 hasPublicationYear "2021" @default.
• W3175278429 type Work @default.
• W3175278429 sameAs 3175278429 @default.
• W3175278429 citedByCount "17" @default.
• W3175278429 countsByYear W31752784292021 @default.
• W3175278429 countsByYear W31752784292022 @default.
• W3175278429 countsByYear W31752784292023 @default.
• W3175278429 crossrefType "journal-article" @default.
• W3175278429 hasAuthorship W3175278429A5002263778 @default.
• W3175278429 hasAuthorship W3175278429A5027619317 @default.
• W3175278429 hasAuthorship W3175278429A5047166582 @default.
• W3175278429 hasAuthorship W3175278429A5056263186 @default.
• W3175278429 hasAuthorship W3175278429A5066645015 @default.
• W3175278429 hasAuthorship W3175278429A5066736885 @default.
• W3175278429 hasAuthorship W3175278429A5082444529 @default.
• W3175278429 hasBestOaLocation W31752784291 @default.
• W3175278429 hasConcept C109650736 @default.

• next